PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Glucose→

Glucose PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
50-99-7
Molecular formula
C6H12O6
Molecular weight
180.16 g/mol
Drug class
Monosaccharide carbohydratemetabolic substrate and intravenous energy/electrolyte vehicle
Mechanism of action
Enters glycolysis and oxidative phosphorylation to produce ATP. Intravenous glucose raises blood glucose and provides substrate for cellular energy metabolism; in hyperinsulinaemic states it counteracts hypoglycaemia.
Indications / reported uses
  • Treatment of hypoglycaemia using oral or intravenous glucose, with concentration and route chosen according to severity and clinical setting
  • Intravenous glucose solutions provide fluid and carbohydrate calories and may be used in perioperative or parenteral nutrition settings; these are formulation-specific uses

Sources: NHS — Low blood sugar (hypoglycaemia) treatment · NLM MeSH — Glucose · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Glucose PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Glucose Permitted Daily Exposure (PDE) report (the Glucose PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Glucose Occupational Exposure Limit (OEL) report (the Glucose OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.